Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
The Effect of Culture on Two Information-Processing Speed Tests.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
Clostridia as agents of zoonotic disease.
Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides.
Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.
Monitoring neuromyelitis optica activity.
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length.
Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-Beta.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
Estimating typical multiple sclerosis disability progression speed from clinical observations.
Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? A systematic review.
Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans.
[Understanding needs of people with Multiple Sclerosis. Perspective of patients and significant others in the German-speaking part of Switzerland].

Pages